Gene targets of antisense therapies in breast cancer

Author： Yang Ding Cheng   Head Jonathan F   Elliott Robert L  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.6, Iss.3, 2002-06, pp. : 375-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer

By  

Current Drug Targets, Vol. 4, Iss. 3, 2003-04 ,pp. : 209-221

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Telomerase by Antisense-Based Approaches: Perspectives for New Anti-Cancer Therapies

By  

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-04 ,pp. : 1105-1117

Bentham Science Publishers

Access to resources Recommend Favorite

Antisense strategies and non-viral gene therapy for cancer

By Bremner K Helen   Read Martin L  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 3, 2002-03 ,pp. : 379-391

Informa Healthcare

Access to resources Recommend Favorite

Potential Novel Targets in Breast Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 2, 2009-02 ,pp. : 148-153

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and Economics of Hormonal Therapies for Advanced Breast Cancer

By Simon Michael S.  

Drugs & Aging, Vol. 19, Iss. 6, 2002-01 ,pp. : 453-463

Adis International

Access to resources Recommend Favorite